antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512 
Mortality of childhood-onset IDDM patients in Estonia
Dear Sir, Insulin-dependent diabetes mellitus (IDDM) leads to excess risk of mortality in developed countries even today [1] . Virtually no data are available on the mortality of IDDM patients in eastern Europe apart from a report from former East Germany on insulin-treated patients [2] . We report the mortality among childhood-onset IDDM patients from Estonia which until 1991 was a constituent republic of the former Soviet Union. Patients were taken from the Estonian population-based childhood-onset IDDM registry which since 1980 has collected information on newly diagnosed cases aged 0--14 years [3] . Between 1 January 1980 and 31 December 1989 340 children were diagnosed with IDDM in Estonia. Registration of cases during 1980-1989 was estimated to be at least 95 % complete using the capture-mark-recapture approach.
The survival status of this cohort was determined as of 1 January 1992. Attending physicians were asked to note the last date when the patient had visited the office or had been hospitalized. Additional information was obtained from currency exchange lists. Currency exchange took place in Estonia in June 1992 and those on the list had to be alive on 1 January 1992. In a minority of cases untraceable by these methods, telephone interviews were conducted and/or the cases traced by mail. Follow-up information was available on 339 cases (99.7 %). The only untraceable case was censored i week after diagnosis as the possibility of death of the patient was excluded. Seven subjects had emigrated and were censored at Corresponding author." T. Podar, MD, Hospital of Endocrinology, Pikk 64, EE-2400 Tartu, Estonia the date last known to be alive. Since information on death certificates is known to be imprecise [4], the cause of death in each case was determined by careful review of hospital records and interviews with physicians and relatives by one of the investigators (T. R). Background data on the mortality of the population of Estonia were obtained from the Department of Epidemiology and Biostatistics, Institute of Experimental and Clinical Medicine. Life-table analysis was used for the assessment of the survival of the cohort. Standardized mortality ratios (SMR) were computed using the computer package PersonYears [5] . 95 % confidence intervals (CI) of SMRs were calculated assuming the Poisson distribution.
The mean duration of follow-up was 6.1 years (range 0. 12). The oldest possible attained age was 26 years. During the follow-up 10 (2.95 %) individuals died, seven male and three female. The crude mortality rate among the cohort was 425 per 100000 person-years. The 10-year cumulative mortality of the cohort was high at 6.1%. The overall SMR (all causes) for the age group 0-29 years was 5.0l (95 % CI 2.41-9.22) ( Table 1) . SMRs for males and females were similar and nonEstonians tended to have a somewhat higher SMR than Estonians (8.85 (95% CI 1.82-25.84) vs 3.50 (95 % CI 1.40-7.21), respectively).
Deaths were most often due to diabetic ketoacidosis, the main killer of the pre-insulin era, which accounted for 50 % of deaths, four in males (57 %) and one in females (33 %). One male died from diabetic ketoacidosis at the onset of IDDM. One female was found dead in bed which could have been related to an acute diabetic complication but the possibility of suicide could not be excluded. One male and one female died because of cancer and two males in motorvehicle accidents. Careful investigation of the circumstances of the accidents revealed that in neither case was diabetes the cause. No deaths were due to chronic complications of IDDM or cardiovascular disease.
Despite the small size of the cohort and small number of deaths, these data should give an adequate estimate of the mortality from childhood-onset IDDM in Estonia. Mortality of the total population of Estonia has been found to be considerably higher than in the developed countries bordering the Baltic Sea [6] . Compared to the background population, the survival of childhood-onset IDDM patients in Estonia is clearly inferior to that of Finland, Sweden, Norway, Israel and Allegheny County (USA) [1, 4, 7] , where the SMR is around 2, but better than in Japan (SMR close to 10) [1] . The mortality of IDDM patients has recently been shown to decline [7] and the Estonian cohort was diagnosed later than those in the above-cited studies.
Most deaths due to diabetic ketoacidosis could have been prevented with better patient education and more resources for self-monitoring. Blood glucose self-monitoring was almost non-existent in Estonia until the end of the 1980s. Patient education was neglected in the former Soviet Union as physicians were thought to be entirely responsible for the health of the patients. The role of the patients themselves in the treatment of IDDM was underemphasized. Eliminating the five deaths clearly due to diabetic ketoacidosis would have reduced the SMR two-fold, to 2.50 (95 % CI 0.81-5.83) similar to levels in Finland and Sweden, and not significantly different from that of the background population. However, the childhood-onset IDDM cohort also seems to be at increased risk for premature death from non-diabetes related causes.
The incidence rates of IDDM in the Baltic region range from 34 in Finland to 10 in Estonia to 6 per 100000 per year in Poland, Lithuania and Latvia [8] . Such a large variation has not yet been explained. The relatively small size of the pool of genetically susceptible individuals in the former socialist countries because of the higher numbers of patients dying before reproduction might be a contributing factor.
Our results demonstrate an alarmingly high proportion of deaths due to diabetic ketoacidosis and inferior survival of childhood-onset IDDM patients from an eastern European country.
Yours sincerely, T. Podar, A. Solntsev, R. E. LaPorte M. Rahu, M. Leinsalu, J. Tuomilehto,
